| ||
| ||
Hot Stocks Insider Trades Radar: Teva Pharmaceutical, Skyworks Solutions ... MarketWatch (press release) VANCOUVER, Dec. 14, 2012 /PRNewswire via COMTEX/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Teva Pharmaceutical (NYSE:TEVA) , Skyworks Solutions (NASDAQ:SWKS) ... See all stories on this topic » | ||
KEMIRA OY : j sells ChemSolutions' food and pharmaceutical businesses to ... 4-traders Kemira Oyj signed an agreement today to sell its food and pharmaceutical businesses together with its acetate based chemicals business to Niacet (Niagara Falls, USA). These businesses are a part of Kemira's ChemSolutions segment. All shares of Kemira ... See all stories on this topic » | ||
CHUGAI PHARMACEUTICAL CO., LTD. : Notice concerning adoption of ... 4-traders Chugai Pharmaceutical Co., Ltd. [Main Office: Chuo-ku, Tokyo. Chairman & CEO: Osamu Nagayama (hereafter, Chugai)] has decided to voluntary adopt International Financial Reporting Standards (IFRS) for use in the consolidated financial statements and ... See all stories on this topic » | ||
China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General ... GlobeNewswire (press release) 14, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of ... See all stories on this topic » | ||
US Corporate Credit Swaps Rise; Teva Pharmaceutical Plans Bond Businessweek A gauge of U.S. corporate credit risk climbed for the first time in four days as concern that budget talks in Washington were stalling offset a bigger-than- expected drop in first-time jobless claims. The Markit CDX North American Investment Grade ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment